| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=1uM, N-{3-[6-(3,6-Dihydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-5-fluoro-2-methyl-phenyl}-2-fluoro-4-(1-hydroxy-1-methyl-ethyl)-benzamide, reversible BTK inhibitor targeting BTK (Novartis, 71230655) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/71230655 |
| Similar Terms | |
| Downloads & Tools |
3 genes differentially expressed following the BC-12-VG35_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| HAO2 | hydroxyacid oxidase 2 (long chain) | 1.88311 |
| ESAM | endothelial cell adhesion molecule | 0.277123 |
| Symbol | Name | Standardized Value |
|---|---|---|
| COX8A | cytochrome c oxidase subunit VIIIA (ubiquitous) | -0.2092 |